Uso ottimale del docetaxel nella chemioterapia adiuvante delle pazienti con carcinoma mammario HER2-negativo

Translated title of the contribution: Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer

S. I S Fattoruso, S. Rossi, P. Vici, F. Di Filippo, C. Botti, L. Di Lauro, P. Foggi, E. Saracca, F. R. Ferranti, P. Visca, M. Lopez

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences